APO RESEARCH · REPORT
Vascular Closure Devices (VCDS)
Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.
Product & engineering
Understand the product.
Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.
Vascular Closure Devices were introduced in the early 1990s in an effort to reduce the time to hemostasis, enable early ambulation and improve patient comfort. Initially, devices focused on technologies involving a suture or a collagen plug. These technologies are effective at closing the hole; however, they often leave an intravascular component in the artery, which can cause complications. In addition, these technologies failed to accurately address patient pain. More recent methods to close the hole involve the use of novel materials that dissolve over a short period of time, such as polyethylene glycol found in the Mynx vascular closure device. These technologies incorporate a more gentle deployment of the material to the outside of the artery and avoid the use of intravascular components, leaving nothing behind in the artery and consequently improving patient comfort.
Generally, there are two types of vascular closure devices: active and passive, in this report, vascular closure devices refer to active vascular closure devices.
Selected research
Market Structure
Global Vascular Closure Devices (VCDS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.
Vascular Closure Devices were introduced in the early 1990s in an effort to reduce the time to hemostasis, enable early ambulation and improve patient comfort. Initially, devices focused on technologies involving a suture or a collagen plug. These technologies are effective at closing the hole; however, they often leave an intravascular component in the artery, which can cause complications. In addition, these technologies failed to accurately address patient pain. More recent methods to close the hole involve the use of novel materials that dissolve over a short period of time, such as polyethylene glycol found in the Mynx vascular closure device. These technologies incorporate a more gentle deployment of the material to the outside of the artery and avoid the use of intravascular components, leaving nothing behind in the artery and consequently improving patient comfort.
Generally, there are two types of vascular closure devices: active and passive, in this report, vascular closure devices refer to active vascular closure devices.
Read the full market overview
Global Vascular Closure Devices (VCDS) key players include Abbott Laboratories, St. Jude Medical, Cardinal Health, etc.
This report provides an overview of the global Vascular Closure Devices (VCDS) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Vascular Closure Devices (VCDS) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Vascular Closure Devices (VCDS) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vascular Closure Devices (VCDS) market size, projected growth trends, production technologies, key applications, and end-use industries.
Vascular Closure Devices (VCDS) Segment by Company
Abbott Laboratories
Abbott
Cardinal Health
Morrris Innovative
Vascular Closure Devices (VCDS) Segment by Type
5F-6F
5F-21F
Vascular Closure Devices (VCDS) Segment by Application
Angiography Surgery
Interventional Procedures
Vascular Closure Devices (VCDS) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Closure Devices (VCDS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vascular Closure Devices (VCDS) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Closure Devices (VCDS).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Vascular Closure Devices (VCDS) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vascular Closure Devices (VCDS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vascular Closure Devices (VCDS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Vascular Closure Devices (VCDS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 5F-6F
- 5F-21F
Applications
- Angiography Surgery
- Interventional Procedures
Companies covered
- Abbott Laboratories
- Abbott
- Cardinal Health
- Morrris Innovative
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Vascular Closure Devices (VCDS) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Vascular Closure Devices (VCDS) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Vascular Closure Devices (VCDS) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Vascular Closure Devices (VCDS) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Vascular Closure Devices (VCDS) Market Dynamics
- 2.1 Vascular Closure Devices (VCDS) Industry Trends
- 2.2 Vascular Closure Devices (VCDS) Industry Drivers
- 2.3 Vascular Closure Devices (VCDS) Industry Opportunities and Challenges
- 2.4 Vascular Closure Devices (VCDS) Industry Restraints
3 Vascular Closure Devices (VCDS) Market by Manufacturers
- 3.1 Global Vascular Closure Devices (VCDS) Revenue by Manufacturers (2021-2026)
- 3.2 Global Vascular Closure Devices (VCDS) Sales by Manufacturers (2021-2026)
- 3.3 Global Vascular Closure Devices (VCDS) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Vascular Closure Devices (VCDS) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vascular Closure Devices (VCDS) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Vascular Closure Devices (VCDS) Manufacturers, Product Type & Application
- 3.7 Global Vascular Closure Devices (VCDS) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Vascular Closure Devices (VCDS) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Vascular Closure Devices (VCDS) Players Market Share by Revenue in 2025
- 3.8.3 2025 Vascular Closure Devices (VCDS) Tier 1, Tier 2, and Tier 3
4 Vascular Closure Devices (VCDS) Market by Type
- 4.1 Vascular Closure Devices (VCDS) Type Introduction
- 4.1.1 5F-6F
- 4.1.2 5F-21F
- 4.2 Global Vascular Closure Devices (VCDS) Sales by Type
- 4.2.1 Global Vascular Closure Devices (VCDS) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Vascular Closure Devices (VCDS) Sales by Type (2021-2032)
- 4.2.3 Global Vascular Closure Devices (VCDS) Sales Market Share by Type (2021-2032)
- 4.3 Global Vascular Closure Devices (VCDS) Revenue by Type
- 4.3.1 Global Vascular Closure Devices (VCDS) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Vascular Closure Devices (VCDS) Revenue by Type (2021-2032)
- 4.3.3 Global Vascular Closure Devices (VCDS) Revenue Market Share by Type (2021-2032)
5 Vascular Closure Devices (VCDS) Market by Application
- 5.1 Vascular Closure Devices (VCDS) Application Introduction
- 5.1.1 Angiography Surgery
- 5.1.2 Interventional Procedures
- 5.2 Global Vascular Closure Devices (VCDS) Sales by Application
- 5.2.1 Global Vascular Closure Devices (VCDS) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Vascular Closure Devices (VCDS) Sales by Application (2021-2032)
- 5.2.3 Global Vascular Closure Devices (VCDS) Sales Market Share by Application (2021-2032)
- 5.3 Global Vascular Closure Devices (VCDS) Revenue by Application
- 5.3.1 Global Vascular Closure Devices (VCDS) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Vascular Closure Devices (VCDS) Revenue by Application (2021-2032)
- 5.3.3 Global Vascular Closure Devices (VCDS) Revenue Market Share by Application (2021-2032)
6 Global Vascular Closure Devices (VCDS) Sales by Region
- 6.1 Global Vascular Closure Devices (VCDS) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Vascular Closure Devices (VCDS) Sales by Region (2021-2032)
- 6.2.1 Global Vascular Closure Devices (VCDS) Sales by Region (2021-2026)
- 6.2.2 Global Vascular Closure Devices (VCDS) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Vascular Closure Devices (VCDS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Vascular Closure Devices (VCDS) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Vascular Closure Devices (VCDS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Vascular Closure Devices (VCDS) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Vascular Closure Devices (VCDS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Vascular Closure Devices (VCDS) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Vascular Closure Devices (VCDS) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Vascular Closure Devices (VCDS) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Vascular Closure Devices (VCDS) Revenue by Region
- 7.1 Global Vascular Closure Devices (VCDS) Revenue by Region
- 7.1.1 Global Vascular Closure Devices (VCDS) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Vascular Closure Devices (VCDS) Revenue by Region (2021-2026)
- 7.1.3 Global Vascular Closure Devices (VCDS) Revenue by Region (2027-2032)
- 7.1.4 Global Vascular Closure Devices (VCDS) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Vascular Closure Devices (VCDS) Revenue (2021-2032)
- 7.2.2 North America Vascular Closure Devices (VCDS) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Vascular Closure Devices (VCDS) Revenue (2021-2032)
- 7.3.2 Europe Vascular Closure Devices (VCDS) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Vascular Closure Devices (VCDS) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Vascular Closure Devices (VCDS) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Vascular Closure Devices (VCDS) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Vascular Closure Devices (VCDS) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Information
- 8.1.2 Abbott Laboratories Business Overview
- 8.1.3 Abbott Laboratories Vascular Closure Devices (VCDS) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Laboratories Vascular Closure Devices (VCDS) Product Portfolio
- 8.1.5 Abbott Laboratories Recent Developments
- 8.2 Abbott
- 8.2.1 Abbott Company Information
- 8.2.2 Abbott Business Overview
- 8.2.3 Abbott Vascular Closure Devices (VCDS) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Abbott Vascular Closure Devices (VCDS) Product Portfolio
- 8.2.5 Abbott Recent Developments
- 8.3 Cardinal Health
- 8.3.1 Cardinal Health Company Information
- 8.3.2 Cardinal Health Business Overview
- 8.3.3 Cardinal Health Vascular Closure Devices (VCDS) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cardinal Health Vascular Closure Devices (VCDS) Product Portfolio
- 8.3.5 Cardinal Health Recent Developments
- 8.4 Morrris Innovative
- 8.4.1 Morrris Innovative Company Information
- 8.4.2 Morrris Innovative Business Overview
- 8.4.3 Morrris Innovative Vascular Closure Devices (VCDS) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Morrris Innovative Vascular Closure Devices (VCDS) Product Portfolio
- 8.4.5 Morrris Innovative Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Vascular Closure Devices (VCDS) Value Chain Analysis
- 9.1.1 Vascular Closure Devices (VCDS) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Vascular Closure Devices (VCDS) Production Mode & Process
- 9.2 Vascular Closure Devices (VCDS) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Vascular Closure Devices (VCDS) Distributors
- 9.2.3 Vascular Closure Devices (VCDS) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst